Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
Abbott, ABC, absence, affiliated, Alnylam, altogether, Amgen, antagonism, appointment, apremilast, automimmune, avoid, Baker, Besancon, bioavailability, Biogen, biomarker, blinded, bone, breakeven, Brenner, broadly, brodalumab, brought, Celgene, characteristic, chemotherapeutic, CHMP, Chugai, circulation, circumstance, clock, companion, complicating, compulsory, conceal, concealing, confer, confirmatory, consolidation, cyclosporine, database, dby, death, decentralized, declassification, declassify, defective, defraud, Department, diagnostic, diffuse, diligent, disagree, dispensing, dispersed, distinct, divert, DLBCL, DOJ, dossier, efficient, ELEVENTH, Eli, EMA, Enbrel, entrench, Epidemiology, essential, Essentially, ETASU, expansion, explanation, facitinib, falsifying, faster, feasibility, forfeited, fraudulent, gastrointestinal, Genentech, geographically, geraghty, Goldberg, Hakko, HIPAA, Humira, hyperviscosity, ibrutinib, Idec, IgM, illustrated, image, IMM, immunoglobulin, immunotoxicity, infiltration, inhibitor, intermediate, irrevocable, irrevocably, isolated, ixekizumab, Janssen, Julian, Justice, justified, Kelvin, kinase, kind, Kirin, Kynamro, Kyowa, leaflet, likelihood, Lilly, lost, lymph, lymphatic, lymphoplasmacytic, MAA, macroglobulinemia, malignant, marker, marrow, meant, messenger, methotrexate, microscopic, Mitsubishi, muscle, mutation, NCI, necessitate, Neu, oncogenic, OPM, opportunity, outweigh, oxygen, parallel, passu, permanent, physician, Portability, preempted, privacy, proliferation, qualification, quantity, question, qui, radiation, radiographic, ratification, reaction, reapprove, reassessed, reassessment, referral, reinstated, relapsed, Remicade, repealing, reward, RLD, RNAi, Roche, Rockefeller, safeguarding, scheme, screening, secukinumab, SEER, Sidney, skeletal, spread, Stelara, Street, strong, sum, supermajority, surrendered, syndrome, Takeda, tam, Tanabe, teaching, thickening, thought, timeframe, tofacitinib, tract, traditional, transmission, Umari, version, viability, viewpoint, waived, waspari, whistleblower
Removed:
abnormal, accrual, achievability, acid, activate, adaptive, allergic, allergy, antitumor, asthma, asthmatic, bacteria, bind, buy, cancellation, cascade, chairman, Circuit, classify, collectability, colorectal, Columbia, computer, contrast, court, culture, cure, cycle, destroy, dilutive, District, dual, earned, EMD, encoded, EUR, existence, expiring, expressed, fall, FASB, fashion, fight, financed, Framework, frequent, handling, hematological, hybridization, hyperlipidemia, imbalance, immunity, increasing, injection, innate, International, intervene, matured, measuring, median, mild, modified, objective, onset, ordinarily, owed, passed, pattern, pioneer, progression, prospectively, pulmonary, ratably, receivable, recognizing, refuse, regimen, respiratory, restoring, standard, stimulated, stimulation, ticker, tied, twelve, unbilled, undertaken, vaccination, validate, vivo, weak, week
Filing tables
Filing exhibits
ACGN similar filings
Filing view
External links